National Research Corporation
National Research Corporation (NRC) Financial Performance & Income Statement Overview
Analyze National Research Corporation (NRC) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
National Research Corporation (NRC) Income Statement & Financial Overview
View the income breakdown for National Research Corporation NRC across both annual and quarterly reports.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Net Income | $5.79M | $6.56M | $5.69M | $6.17M |
Depreciation & Amortization | $1.54M | $1.52M | $1.55M | $1.51M |
Deferred Income Tax | $1.94M | -$499000.00 | $90000.00 | $116000.00 |
Stock Based Compensation | $171000.00 | $188000.00 | $189000.00 | -$57000.00 |
Change In Working Capital | -$2.90M | -$1.46M | $1.89M | -$951000.00 |
Accounts Receivables | -$272000.00 | $5000.00 | -$569000.00 | $1.07M |
Inventory | $0.00 | $0.00 | $0.00 | $0.00 |
Accounts Payables | $627000.00 | -$707000.00 | $566000.00 | $184000.00 |
Other Working Capital | -$3.26M | -$761000.00 | $1.89M | -$2.21M |
Other Non-Cash Items | $113000.00 | $77000.00 | $23000.00 | -$56000.00 |
Net Cash From Operating Activities | $6.65M | $6.38M | $9.42M | $6.79M |
Investments In Property Plant & Equipment | -$2.99M | -$4.44M | -$1.60M | -$5.27M |
Acquisitions Net | $0.00 | -$4.83M | -$4.83M | $0.00 |
Purchases Of Investments | $0.00 | $0.00 | $0.00 | $0.00 |
Sales/Maturities Of Investments | $0.00 | $0.00 | $0.00 | $0.00 |
Other Investing Activities | $0.00 | $0.00 | $0.00 | $0.00 |
Net Cash Used For Investing Activities | -$2.99M | -$4.44M | -$6.43M | -$5.27M |
Debt Repayment | $2.51M | $9.05M | $11.43M | $136000.00 |
Common Stock Issued | $0.00 | $0.00 | $0.00 | $0.00 |
Common Stock Repurchased | -$4.92M | -$7.40M | -$8.55M | $0.00 |
Dividends Paid | -$2.77M | -$2.82M | -$2.86M | -$2.87M |
Other Financing Activities | -$210000.00 | -$5000.00 | $15000.00 | $0.00 |
Net Cash From Financing Activities | -$5.39M | -$1.16M | -$17000.00 | -$2.73M |
Effect Of Forex Changes On Cash | $0.00 | $0.00 | $0.00 | -$1000.00 |
Net Change In Cash | -$1.73M | $772000.00 | $2.98M | -$1.21M |
Cash At End Of Period | $2.50M | $4.23M | $3.46M | $485000.00 |
Cash At Beginning Of Period | $4.23M | $3.46M | $485000.00 | $1.70M |
Operating Cash Flow | $6.65M | $6.38M | $9.42M | $6.79M |
Capital Expenditure | -$2.99M | -$4.44M | -$1.60M | -$5.27M |
Free Cash Flow | $3.66M | $1.94M | $7.83M | $1.52M |
National Research Corporation (NRC) Cash Flow Analysis
Operating within the Medical - Healthcare Information Services industry under the Healthcare sector, National Research Corporation is trading at $13.85 and currently holds a market capitalization of N/A.
Cash Flow Overview
National Research Corporation's cash flow assessment details how it manages money across operations, investments, and financing. This financial overview reflects the company's ability to fund activities, sustain growth, and respond to market conditions.
Key Cash Flow Metrics
Financial Position Indicators
Stock Performance Summary
The data below highlights National Research Corporation's results over various time intervals.
Company Information
Investment Metrics
Understanding Cash Flow Statements
Cash flow statements are crucial financial documents that track the movement of cash in and out of a business. Unlike income statements that may include non-cash items, cash flow statements focus exclusively on actual cash transactions.
Three Components of Cash Flow:
Operating Activities
Revenue-related cash flow from operations
Investing Activities
Investment-related cash outflows for acquisitions, securities, or physical assets
Financing Activities
Proceeds from debt issuance, equity funding, and dividends
Data Update: Financial data is updated regularly based on company filings. Last earnings announcement: October 24, 2025.All financial metrics are trailing twelve months (TTM) unless otherwise specified. Currency: USD. Exchange: NASDAQ.
Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. Please conduct your own research and consult with financial advisors before making investment decisions.
National Research Corporation (NRC) Cash Flow Analysis
The cash flow statement reveals the National Research Corporation (NRC) liquidity trends, with operating cash flow per share at $1.29, reflecting core business performance. Investing activity changes were 8.25%, indicating capital expenditures or asset sales, while financing activity shifted by 60.91%, showing debt or equity movements. Free cash flow per share was $0.66, highlighting funds available for growth or shareholder returns. Year-over-year change in operating cash flow is -9.15%, demonstrating financial health shifts. For deeper insights, compare these figures with income statements and balance sheets to assess sustainability and strategic priorities.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan